Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Apply a small amount to a clean, dry or towel-dried scalp
Additionally, bacteriostatic water is contraindicated for neonates due to benzyl alcohol toxicity, while preservative-free sterile water is safe for this population
Inclusion Criteria Exclusion Criteria Timeline for a Trial Participant Screening Participants are screened for eligibility to participate in the trial Treatment Participants receive weekly subcutaneous injections of either CagriSema or Tirzepatide, with a dose escalation period followed by maintenance dosing Follow-up Participants are monitored for safety and effectiveness after treatment What Are the Treatments Tested in This Trial
BPC-157 / TB-500 Blend 10mg The BPC-157 and TB-500 blend combines two of the most researched regenerative peptides into a single, convenient vial
Participants were randomized in a 2:1:1:1:1:2:2 ratio to once-weekly subcutaneous retatrutide at 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, over a 48-week treatment period
US$ 29.74
US$ 24.43
US$ 23.54
